Coronavirus: Medical Treatments

(asked on 8th February 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had experts on the use of covid-19 blood plasma to help treat people with covid-19.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 24th February 2021

Convalescent plasma was trialled as a treatment for COVID-19 in hospitalised patients in the RECOVERY and REMAP-CAP trial platforms in the United Kingdom. The interim analysis from both trials on 7 January 2021 revealed no benefit of convalescent plasma for patients with severe disease including patients requiring mechanical ventilation and organ support.

The RECOVERY trial closed recruitment on 15 January and reported no overall mortality benefit for other hospitalised patients. However, both trials are continuing to analyse the data, as it is possible that convalescent plasma could provide clinical benefit for specific sub-groups of patients.

Reticulating Splines